Net profit of Bafna Pharmaceuticals declined 72.81% to Rs 1.46 crore in the quarter ended March 2024 as against Rs 5.37 crore during the previous quarter ended March 2023. Sales declined 1.99% to Rs 41.40 crore in the quarter ended March 2024 as against Rs 42.24 crore during the previous quarter ended March 2023.
For the full year,net profit declined 35.19% to Rs 7.35 crore in the year ended March 2024 as against Rs 11.34 crore during the previous year ended March 2023. Sales rose 32.18% to Rs 152.47 crore in the year ended March 2024 as against Rs 115.35 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 41.40 | 42.24 | -2 | 152.47 | 115.35 | 32 |
| OPM % | 6.98 | 18.04 | - | 7.29 | 13.63 | - |
| PBDT | 2.73 | 7.18 | -62 | 12.35 | 16.95 | -27 |
| PBT | 1.46 | 5.65 | -74 | 7.35 | 11.62 | -37 |
| NP | 1.46 | 5.37 | -73 | 7.35 | 11.34 | -35 |